NNVC NanoViricides Corp: רווח למניה לשנה מתגלגלת

NanoViricides, Inc. (NNVC) is consuming capital for the R&D stage in the absence of sales, offsetting the liquidity deficit through partnerships with global virologists to create nanotraps. The relative change in EPS YoY (ttm) on the GURU.Markets terminal chart shows that the 35.90 level is the current value. Growth prospects are based on a platform of universal drugs against herpes and influenza.
NanoViricides, Inc. - פילוחים אנליטיים ומדדי מפתח (NNVC)

This indicator captures the percentage change in net earnings per share over the last twelve months relative to the same period last year, measuring the scaling rate of the business's actual earnings. By analyzing the year-over-year EPS dynamics (TTM), an investor assesses the commercialization efficiency of NanoViricides, Inc. nanotechnology virus traps within the infectious disease combat segment.